Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Source: 
Endpoints
snippet: 

Oyster Point Pharma — a small Princeton, NJ-based biotech looking to disrupt a massive eye drug market largely monopolized by two therapies — has positive pivotal trial data as it marches on a path towards US approval.